Fendrix

Fendrix is a vaccine designed to prevent hepatitis B infection. It contains Aluminium Phosphate and Hepatitis B Surface Antigen, adjuvanted by AS04C and adsorbed on Aluminium. This intramuscular vaccine is manufactured by Glaxosmithkline Biologicals S.A.

Fendrix is primarily used for the prevention of hepatitis B infection. It is administered intramuscularly and is intended for individuals who are at risk of contracting the virus. The vaccine works by stimulating the body's immune response to the hepatitis B surface antigen, helping to build immunity against the virus.

Common effects of Fendrix may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience temporary fatigue, headache, or mild fever. These effects are generally mild and short-lived.

Fendrix should be handled with care and stored according to the manufacturer's guidelines. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Follow the recommended dosage and administration instructions provided by a healthcare professional.

Fendrix may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Fendrix. Avoid alcohol consumption before and after receiving the vaccine, as it may affect the body's immune response.